CAS 84625-61-6

Itraconazol

Descripción:

Itraconazol es un agente antifúngico triazólico que se utiliza principalmente para tratar diversas infecciones fúngicas, incluidas las causadas por dermatofitos, levaduras y ciertos mohos. Funciona inhibiendo la síntesis de ergosterol, un componente esencial de las membranas celulares fúngicas, interrumpiendo así su integridad y función. Itraconazol se caracteriza por su relativamente baja solubilidad en agua, pero es más soluble en disolventes orgánicos, lo que influye en su biodisponibilidad. El compuesto tiene una fórmula molecular de C35H38Cl2N8O4S y presenta una estructura compleja que incluye un anillo triazólico. Se administra típicamente por vía oral o intravenosa, con su farmacocinética influenciada por factores como la ingesta de alimentos y los niveles de pH. Itraconazol es conocido por su amplio espectro de actividad contra varios hongos, pero también puede interactuar con otros medicamentos debido a sus efectos sobre las enzimas hepáticas. Los efectos secundarios comunes pueden incluir trastornos gastrointestinales, elevaciones de las enzimas hepáticas y posibles efectos cardiovasculares, lo que requiere un monitoreo durante el tratamiento.

Fórmula: C₃₅H₃₈Cl₂N₈O₄

InChI: InChI=1/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/s2

Clave InChI: InChIKey=VHVPQPYKVGDNFY-WGEGMAFPNA-N

SMILES: C([C@]1(O[C@@H](COC2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)N5C(=O)N(C(CC)C)N=C5)CO1)C6=C(Cl)C=C(Cl)C=C6)N7C=NC=N7

Sinónimos:

• 2-Butan-2-Yl-4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1,2,4-Triazol-1-Yl Methyl)-1,3-Dioxolan-4-Yl]Methoxy]Phenyl]Piperazin-1-Yl]Phenyl]-1,2,4-Triazol-3-One
• 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-, rel-
• 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-
• Candistat
• Canditral
• Cladosal 100
• Fungitraxx
• Itrac
• Itraconozole
• Itralek
• Itrizole
• Oriconazole
• Orungal
• Orungamin
• Pur 1900
• R 51211
• SUBA Itraconazole
• Sempera
• Spherazole CR
• Spherazole IR
• Sporal
• Sporamelt
• Sporanox
• Sporanox IV
• Sporonox
• Traconal
• Triasporin
• cis-Itraconazole
• rel-4-[4-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one

Itraconazole-d9

Producto controlado

CAS: 84625-61-6

Applications Itraconazole-d9, is the labeled analogue of Itraconazole (I937500, an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product.
References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984), Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989), Sugar, A.M., et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993),

Fórmula: C₃₅H₂₉D₉Cl₂N₈O₄

Forma y color: Off-White To Beige

Peso molecular: 714.69

Ref: TR-I937504

Itraconazole

Producto controlado

CAS: 84625-61-6

Applications Itraconazole is an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product.
References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984); Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989); Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993);

Fórmula: C₃₅H₃₈Cl₂N₈O₄

Forma y color: White To Off-White

Peso molecular: 705.63

Ref: TR-I937500

Itraconazole - Bio-X ™

CAS: 84625-61-6

Itraconazole is an anti-fungal drug that inhibits the synthesis of ergosterol, a component of the fungal cell membrane. Itraconazole is in a class of antifungals called triazoles. The drug binds to ergosterol in the fungal cell membrane and prevents it from being inserted into the membrane. This decreases the permeability of the plasma membrane, causing leakage of cellular contents. Additionally, it has been shown to have a glucose-lowering effect in the treatment of acute leukaemia and may be used for research in aiding to diagnose hematopoietic stem cell or leukaemia.

Fórmula: C₃₅H₃₈Cl₂N₈O₄

Pureza: Min. 98 Area-%

Forma y color: Powder

Peso molecular: 705.63 g/mol

Ref: 3D-BI164594

Itraconazole

CAS: 84625-61-6

Itraconazole is an anti-fungal drug that inhibits the synthesis of ergosterol, a component of the fungal cell membrane. It also has been shown to have a glucose-lowering effect in the treatment of acute leukemia and may be used to diagnose hematopoietic stem cell or leukemia. Itraconazole is available as an oral tablet and can be administered for primary care in patients with wild-type strains of Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Histoplasma capsulatum, and Trichophyton mentagrophytes. The drug binds to ergosterol in the fungal cell membrane and prevents it from being inserted into the membrane. This decreases the permeability of the plasma membrane, causing leakage of cellular contents.

Fórmula: C₃₅H₃₈Cl₂N₈O₄

Pureza: Min. 98.5 Area-%

Forma y color: White Powder

Peso molecular: 705.63 g/mol

Ref: 3D-FB24741